Author:
Pore Debasis,Chakrabarti Manoj K.
Reference25 articles.
1. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD et al (1999) Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 77:651–666
2. Ashkenazi S, Levy I, Kazaronovsky V, Samra Z (2003) Growing antimicrobial resistance of Shigella isolates. J Antimicrob Chemother 51:427–429
3. Noriega FR, Wang JY, Losonsky G, Maneval DR et al (1994) Construction and characterization of attenuated (delta)aroA (delta)virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine. Infect Immun 62:5168–5172
4. Sansonetti PJ (1991) Genetic and molecular basis of epithelial cell invasion by Shigella species. Rev Infect Dis 13:S285–S292
5. Orr N, Robin G, Cohen D, Arnon R, Lowell GH (1993) Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. Infect Immun 61:2390–2395
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献